Scholars Central

Review articlePublished 23 Apr 2011

Anthrax Bioterrorism: Prevention, Diagnosis and Management Strategies

Authors: Robert A Fowler, Shirin Shafaz

Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada; University of Miami, Miller School of Medicine, Miami, USA

Journal of Bioterrorism & Biodefense

Volume 2 · Issue 2 · Pages 1–10

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bacillus anthracis is one of a limited number of biological agents capable of causing death and disease in sufficient numbers to devastate an urban setting. In October 2001, reports of American patients with inhalational anthrax reacquainted the public with this ancient disease and introduced the harsh reality of a bioterrorist act. Cutaneous disease, gastrointestinal anthrax and inhalational disease are the known clinical manifestations of anthrax. Inhalational anthrax has an untreated mortality of nearly 100% and is the primary cause of death for an exposed and unprotected population. Vaccination affords a high degree of primary prevention and multiple effective antibiotics exist for both disease prevention and treatment. In this article, we will discuss the costs and effectiveness of prevention strategies, diagnosis, and therapy of bioterrorism related anthrax.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Bioterrorism & Biodefense.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioterrorism & Biodefense
  • SubjectMicrobiology
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Robert A Fowler”
  • BylineArticles whose byline prints “Shirin Shafaz”